A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

导出 LinkOut

翻译打印收藏纠错

作者： Yukinobu,Watanabe ^[1] ; Masahiro,Ogawa ^[1] ; Yu,Tamura ^[1] ; Seiichiro,Suda ^[1] ; Masahiro,Kaneko ^[1] ; Mariko,Kumagawa ^[1] ; Midori,Hirayama ^[1] ; Naoki,Matsumoto ^[1] ; Toshiki,Yamamoto ^[1] ; Mitsuhiko,Moriyama ^[1]

作者单位： Nihon University School of Medicine, Tokyo, Japan. ^[1]

关键词 Hepatocellular carcinoma atezolizumab bevacizumab immune checkpoint inhibitor pseudoprogression

主题词老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 肝细胞(Carcinoma, Hepatocellular);化学栓塞, 治疗性(Chemoembolization, Therapeutic);人类(Humans);肝肿瘤(Liver Neoplasms);男(雄)性(Male)

DOI 10.1177/23247096211058489

PMID 34845921

发布时间 2021-12-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of investigative medicine high impact case reports

23247096211058489页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

Journal of investigative medicine high impact case reports

相似文献

Journal of investigative medicine high impact case reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

Journal of investigative medicine high impact case reports

相似文献

Journal of investigative medicine high impact case reports

相关期刊

检索历史清除